Ocular Drug Delivery Devices Market Players:
- Bausch Health Companies Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Taiwan Liposome Company, Ltd.
- Ocular Therapeutix, Inc.
- Kiora Pharmaceuticals, Inc.
- Graybug Vision Inc.
- Apellis Pharmaceuticals, Inc.
- Implanet Company
- Aerie Pharmaceuticals Inc.
- EyePoint Pharmaceuticals, Inc.
- Protalix BioTherapeutics
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of ocular drug delivery devices is evaluated at USD 17.81 billion.
The global ocular drug delivery devices market size was worth over USD 16.66 billion in 2025 and is poised to grow at a CAGR of around 7.7%, reaching USD 34.98 billion revenue by 2035.
North America is projected to command the largest revenue share of the ocular drug delivery devices market by 2035, attributed to rising cases of cataracts and diabetes-related visual conditions across the region.
Key players in the market include Repsol, S.A., China Petroleum & Chemical Corporation, ExxonMobil Corporation, Valero Energy Corporation, Marathon Petroleum Corporation, Shell International B.V., Petróleo Brasileiro S.A., Chevron Corporation, Schlumberger Limited, CNOOC Limited.
